{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:13:00Z","timestamp":1793236380579,"version":"4.5.0"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008679","name":"Universidad de C\u00f3rdoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.molmet.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T11:39:23Z","timestamp":1580902763000},"page":"100937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":494,"special_numbering":"C","title":["Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies"],"prefix":"10.1016","volume":"35","author":[{"given":"Miguel A.","family":"Sanchez-Garrido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Tena-Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.molmet.2020.01.001_bib1","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Human Reproduction Update"},{"issue":"56","key":"10.1016\/j.molmet.2020.01.001_bib3","doi-asserted-by":"crossref","first-page":"96351","DOI":"10.18632\/oncotarget.19180","article-title":"The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis","volume":"8","author":"Ding","year":"2017","journal-title":"OncoTarget"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0889-8529(03)00044-6","article-title":"Assessment and management of anovulatory infertility in polycystic ovary syndrome","volume":"32","author":"Franks","year":"2003","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.molmet.2020.01.001_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13828","article-title":"Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews","author":"Gilbert","year":"2018","journal-title":"Clinical Endocrinology (Oxf)"},{"key":"10.1016\/j.molmet.2020.01.001_bib7","first-page":"317241","article-title":"Obesity differentially affects phenotypes of polycystic ovary syndrome","author":"Moran","year":"2012","journal-title":"The Internet Journal of Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls","volume":"59","author":"Legro","year":"2004","journal-title":"Obstetrical and Gynecological Survey"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fertnstert.2011.11.036","article-title":"Should all women with PCOS be treated for insulin resistance?","volume":"97","author":"Marshall","year":"2012","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.17219\/acem\/59380","article-title":"The pathogenesis and treatment of polycystic ovary syndrome: what's new?","volume":"26","author":"Bednarska","year":"2017","journal-title":"Advances in Clinical and Experimental Medicine"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Human Reproduction Update"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-016-0203-8","article-title":"Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis","volume":"14","author":"Yang","year":"2016","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"10","key":"10.1016\/j.molmet.2020.01.001_bib13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","article-title":"The impact of obesity on reproduction in women with polycystic ovary syndrome","volume":"113","author":"Pasquali","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.molmet.2020.01.001_bib14","doi-asserted-by":"crossref","first-page":"719050","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas","year":"2014","journal-title":"International Journal of Reproductive Medicine"},{"key":"10.1016\/j.molmet.2020.01.001_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clinical Epidemiology"},{"key":"10.1016\/j.molmet.2020.01.001_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/IJWH.S11304","article-title":"Treatment options for polycystic ovary syndrome","volume":"3","author":"Badawy","year":"2011","journal-title":"International Journal of Womens Health"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ando.2017.04.024","article-title":"Which origin for polycystic ovaries syndrome: genetic, environmental or both?","volume":"78","author":"Fenichel","year":"2017","journal-title":"Annales d'Endocrinologie"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nature Reviews Endocrinology"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Molecular Endocrinology"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.20945\/2359-3997000000049","article-title":"An update of genetic basis of PCOS pathogenesis","volume":"62","author":"Crespo","year":"2018","journal-title":"Archives Endocrinology Metabol"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1095\/biolreprod.103.026732","article-title":"Colocalization of P450c17 and cytochrome b5 in androgen-synthesizing tissues of the human","volume":"71","author":"Dharia","year":"2004","journal-title":"Biology of Reproduction"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocrine Reviews"},{"issue":"33","key":"10.1016\/j.molmet.2020.01.001_bib23","doi-asserted-by":"crossref","first-page":"12435","DOI":"10.1073\/pnas.0603006103","article-title":"Follicle-stimulating hormone\/cAMP regulation of aromatase gene expression requires beta-catenin","volume":"103","author":"Parakh","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1677\/joe.0.1290317","article-title":"The ubiquitous polycystic ovary","volume":"129","author":"Franks","year":"1991","journal-title":"Journal of Endocrinology"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib25","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1210\/jcem-63-5-1204","article-title":"Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test","volume":"63","author":"Wajchenberg","year":"1986","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0889-8529(05)70074-8","article-title":"Insulin action in the normal and polycystic ovary","volume":"28","author":"Franks","year":"1999","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.fertnstert.2003.07.008","article-title":"Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess","volume":"81","author":"Moran","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","article-title":"Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)","volume":"62","author":"Kumar","year":"2005","journal-title":"Clinical Endocrinology (Oxf)"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome","volume":"47","author":"Gilling-Smith","year":"1997","journal-title":"Clinical Endocrinology (Oxf)"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2006.01.003","article-title":"Human ovarian theca cells in culture","volume":"17","author":"Wickenheisser","year":"2006","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nature Reviews Endocrinology"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","article-title":"The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome","volume":"12","author":"Blank","year":"2006","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.molmet.2020.01.001_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2018.08.005","article-title":"New perspectives on the pathogenesis of PCOS: neuroendocrine origins","author":"Walters","year":"2018","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.01.001_bib34","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nature Communications"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2020.01.001_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2005.07.002","article-title":"Insulin regulation of GnRH gene expression through MAP kinase signaling pathways","volume":"242","author":"Kim","year":"2005","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.fertnstert.2006.12.055","article-title":"Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity","volume":"88","author":"Baillargeon","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/jc.2005-1804","article-title":"Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?","volume":"91","author":"Baillargeon","year":"2006","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib39","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","article-title":"On the paradox of insulin-induced hyperandrogenism in insulin-resistant states","volume":"12","author":"Poretsky","year":"1991","journal-title":"Endocrine Reviews"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A\u00a0direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jcem-67-3-460","article-title":"Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin","volume":"67","author":"Plymate","year":"1988","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib43","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib45","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/GCO.0b013e32833e1264","article-title":"Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update","volume":"22","author":"Katsiki","year":"2010","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib47","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ncpendmet0787","article-title":"Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal","volume":"4","author":"Dunaif","year":"2008","journal-title":"Nature Clinical Practice Endocrinology & Metabolism"},{"key":"10.1016\/j.molmet.2020.01.001_bib48","doi-asserted-by":"crossref","first-page":"73986","DOI":"10.1155\/PPAR\/2006\/73986","article-title":"Thiazolidinediones and fertility in polycystic ovary syndrome (PCOS)","volume":"2006","author":"Froment","year":"2006","journal-title":"PPAR Research"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1389201015666140330195142","article-title":"The utility of metformin therapy in reproductive-aged women with polycystic ovary syndrome (PCOS)","volume":"15","author":"Nathan","year":"2014","journal-title":"Current Pharmaceutical Biotechnology"},{"issue":"8489","key":"10.1016\/j.molmet.2020.01.001_bib50","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(86)91340-1","article-title":"Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales","volume":"1","author":"Barker","year":"1986","journal-title":"Lancet"},{"issue":"8850","key":"10.1016\/j.molmet.2020.01.001_bib51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0140-6736(93)91224-A","article-title":"Fetal nutrition and cardiovascular disease in adult life","volume":"341","author":"Barker","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/humupd\/dmx013","article-title":"Is foetal hyperexposure to androgens a cause of PCOS?","volume":"23","author":"Filippou","year":"2017","journal-title":"Human Reproduction Update"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib53","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ajp.20679","article-title":"Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys","volume":"71","author":"Abbott","year":"2009","journal-title":"American Journal of Primatology"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Human Reproduction Update"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib55","doi-asserted-by":"crossref","first-page":"E262","DOI":"10.1152\/ajpendo.90208.2008","article-title":"Transient prenatal androgen exposure produces metabolic syndrome in adult female rats","volume":"295","author":"Demissie","year":"2008","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib56","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1095\/biolreprod.105.039800","article-title":"Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator","volume":"72","author":"Foecking","year":"2005","journal-title":"Biology of Reproduction"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib57","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1210\/en.2014-1609","article-title":"Prenatal testosterone treatment leads to changes in the morphology of KNDy neurons, their inputs, and projections to GnRH cells in female sheep","volume":"156","author":"Cernea","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2020.01.001_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000134831","article-title":"Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome","volume":"13","author":"Abbott","year":"2008","journal-title":"Endocrine Development"},{"issue":"12","key":"10.1016\/j.molmet.2020.01.001_bib59","doi-asserted-by":"crossref","first-page":"E1321","DOI":"10.1152\/ajpendo.00620.2012","article-title":"Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice","volume":"304","author":"Nohara","year":"2013","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib60","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocrine Reviews"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib61","first-page":"1328","article-title":"Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women","volume":"79","author":"Barnes","year":"1994","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib62","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1365-2265.2012.04443.x","article-title":"Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study","volume":"77","author":"Palomba","year":"2012","journal-title":"Clinical Endocrinology"},{"issue":"10","key":"10.1016\/j.molmet.2020.01.001_bib63","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","article-title":"Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization","volume":"17","author":"Sir-Petermann","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.molmet.2020.01.001_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2015.11.030","article-title":"Effect of maternal PCOS and PCOS-like phenotype on the offspring's health","volume":"435","author":"Puttabyatappa","year":"2016","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejogrb.2012.10.015","article-title":"Placental steroidogenesis in pregnant women with polycystic ovary syndrome","volume":"166","author":"Maliqueo","year":"2013","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib66","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nature Medicine"},{"issue":"9085","key":"10.1016\/j.molmet.2020.01.001_bib67","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(97)06062-5","article-title":"Fetal growth, length of gestation, and polycystic ovaries in adult life","volume":"350","author":"Cresswell","year":"1997","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib68","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF03350781","article-title":"Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset","volume":"21","author":"Ibanez","year":"1998","journal-title":"Journal of Endocrinological Investigation"},{"issue":"7","key":"10.1016\/j.molmet.2020.01.001_bib69","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.metabol.2008.02.018","article-title":"Low birth weight and later development of insulin resistance and biochemical\/clinical features of polycystic ovary syndrome","volume":"57","author":"Pandolfi","year":"2008","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.molmet.2020.01.001_bib70","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/humrep\/deq162","article-title":"High prevalence of polycystic ovary syndrome in women born small for gestational age","volume":"25","author":"Melo","year":"2010","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/ENDO:30:1:19","article-title":"The role of genes and environment in the etiology of PCOS","volume":"30","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib72","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clinical Endocrinology (Oxf)"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib74","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1289\/ehp.0901257","article-title":"Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats","volume":"118","author":"Fernandez","year":"2010","journal-title":"Environmental Health Perspectives"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib75","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/toxsci\/kfq186","article-title":"Estrogenicity of bisphenol a: a concentration-effect relationship on luteinizing hormone secretion in a sensitive model of prepubertal lamb","volume":"117","author":"Collet","year":"2010","journal-title":"Toxicological Sciences"},{"issue":"7","key":"10.1016\/j.molmet.2020.01.001_bib76","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1210\/en.2014-1634","article-title":"Acute influences of bisphenol A exposure on hypothalamic release of gonadotropin-releasing hormone and Kisspeptin in female rhesus monkeys","volume":"156","author":"Kurian","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2020.01.001_bib77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.envint.2013.12.007","article-title":"Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives","volume":"64","author":"Rezg","year":"2014","journal-title":"Environment International"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib78","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/09513590.2017.1405931","article-title":"The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"34","author":"Hu","year":"2018","journal-title":"Gynecological Endocrinology"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib79","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1210\/jc.2008-0369","article-title":"Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries","volume":"93","author":"Franks","year":"2008","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"25","key":"10.1016\/j.molmet.2020.01.001_bib80","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib81","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2020.01.001_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101606","article-title":"The genetics of polycystic ovary syndrome: an overview of candidate gene systematic reviews and genome-wide association studies","volume":"8","author":"Hiam","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.molmet.2020.01.001_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.lfs.2018.05.052","article-title":"Hypomethylation of specific CpG sites in the promoter region of steroidogeneic genes (GATA6 and StAR) in prenatally androgenized rats","volume":"207","author":"Salehi Jahromi","year":"2018","journal-title":"Life Sciences"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib84","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.fertnstert.2014.07.1203","article-title":"Genome-wide identification of aberrantly methylated promoters in ovarian tissue of prenatally androgenized rats","volume":"102","author":"Zhang","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1016\/j.molmet.2020.01.001_bib85","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1210\/en.2019-00389","article-title":"Developmental programming: contribution of epigenetic enzymes to antral follicular defects in the sheep model of PCOS","volume":"160","author":"Guo","year":"2019","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.molmet.2020.01.001_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027286","article-title":"Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys","volume":"6","author":"Xu","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib87","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/molehr\/gap089","article-title":"Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome","volume":"16","author":"Zhu","year":"2010","journal-title":"Molecular Human Reproduction"},{"issue":"8","key":"10.1016\/j.molmet.2020.01.001_bib88","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00109-012-0881-4","article-title":"A\u00a0molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells","volume":"90","author":"Qu","year":"2012","journal-title":"Journal of Molecular Medicine (Berlin)"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib89","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/edrv-14-1-72","article-title":"Genetic and nongenetic determinants of regional fat distribution","volume":"14","author":"Bouchard","year":"1993","journal-title":"Endocrine Reviews"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib90","first-page":"157","article-title":"Body fat topography in women with androgen excess","volume":"12","author":"Evans","year":"1988","journal-title":"International Journal of Obesity"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib91","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2012-3698","article-title":"Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS)","volume":"98","author":"Borruel","year":"2013","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2020.01.001_bib92","first-page":"2044","article-title":"Long-term testosterone administration increases visceral fat in female to male transsexuals","volume":"82","author":"Elbers","year":"1997","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2020.01.001_bib93","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study","volume":"91","author":"Gambineri","year":"2006","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib94","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1038\/s41598-017-09723-y","article-title":"Body fat distribution and the risk of incident metabolic syndrome: a longitudinal Cohort study","volume":"7","author":"Kwon","year":"2017","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib95","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/oby.20719","article-title":"Central mechanisms of adiposity in adult female mice with androgen excess","volume":"22","author":"Nohara","year":"2014","journal-title":"Obesity (Silver Spring)"},{"issue":"36","key":"10.1016\/j.molmet.2020.01.001_bib96","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.2174\/1381612822666160726103133","article-title":"Polycystic ovary syndrome as a proinflammatory state: the role of adipokines","volume":"22","author":"Dimitriadis","year":"2016","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.molmet.2020.01.001_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.steroids.2017.12.009","article-title":"Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome","volume":"130","author":"Echiburu","year":"2018","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib98","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib99","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.fertnstert.2007.03.085","article-title":"Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome","volume":"89","author":"Carmina","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1016\/j.molmet.2020.01.001_bib100","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","article-title":"A\u00a0new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome","volume":"148","author":"Manneras","year":"2007","journal-title":"Endocrinology"},{"issue":"19","key":"10.1016\/j.molmet.2020.01.001_bib101","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.lfs.2007.02.013","article-title":"Impairment in insulin sensitivity after early androgenization in the post-pubertal female rat","volume":"80","author":"Perello","year":"2007","journal-title":"Life Sciences"},{"issue":"7","key":"10.1016\/j.molmet.2020.01.001_bib102","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1177\/1933719117746767","article-title":"Developmental programming: impact of prenatal testosterone excess on steroidal machinery and cell differentiation markers in visceral adipocytes of female sheep","volume":"25","author":"Puttabyatappa","year":"2018","journal-title":"Reproductive Sciences"},{"issue":"7","key":"10.1016\/j.molmet.2020.01.001_bib103","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1210\/en.2014-1050","article-title":"Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys","volume":"155","author":"Keller","year":"2014","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib104","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/endo.141.2.7293","article-title":"Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2","volume":"141","author":"Dieudonne","year":"2000","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2020.01.001_bib105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2008.08.019","article-title":"Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes","volume":"296","author":"Gupta","year":"2008","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib106","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2265.2009.03645.x","article-title":"Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women","volume":"72","author":"Blouin","year":"2010","journal-title":"Clinical Endocrinology"},{"issue":"34","key":"10.1016\/j.molmet.2020.01.001_bib107","doi-asserted-by":"crossref","first-page":"30998","DOI":"10.1074\/jbc.M204527200","article-title":"Regulation of Wnt signaling during adipogenesis","volume":"277","author":"Bennett","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"5481","key":"10.1016\/j.molmet.2020.01.001_bib108","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.289.5481.950","article-title":"Inhibition of adipogenesis by Wnt signaling","volume":"289","author":"Ross","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2004-1649","article-title":"Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors","volume":"147","author":"Singh","year":"2006","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A\u00a0prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib111","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.molmet.2020.01.001_bib112","doi-asserted-by":"crossref","first-page":"16147","DOI":"10.1074\/jbc.274.23.16147","article-title":"Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma","volume":"274","author":"Heinlein","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib113","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.steroids.2013.05.001","article-title":"Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation","volume":"78","author":"Chazenbalk","year":"2013","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib114","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-003-1324-0","article-title":"Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots","volume":"47","author":"Dicker","year":"2004","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1463-1326.2002.00214.x","article-title":"The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue","volume":"4","author":"Anderson","year":"2002","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"11","key":"10.1016\/j.molmet.2020.01.001_bib116","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1210\/en.2013-1428","article-title":"Ovarian cycle-specific regulation of adipose tissue lipid storage by testosterone in female nonhuman primates","volume":"154","author":"Varlamov","year":"2013","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib117","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/humrep\/dex244","article-title":"Combined androgen excess and Western-style diet accelerates adipose tissue dysfunction in young adult, female nonhuman primates","volume":"32","author":"Varlamov","year":"2017","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib118","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.fertnstert.2006.11.088","article-title":"Effects of testosterone and estrogen treatment on lipolysis signaling pathways in subcutaneous adipose tissue of postmenopausal women","volume":"88","author":"Zang","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib119","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","article-title":"AKR1C3-Mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib120","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2337\/diabetes.51.9.2734","article-title":"Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein","volume":"51","author":"Nishizawa","year":"2002","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib121","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2010-1290","article-title":"Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manneras-Holm","year":"2011","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib122","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/en.2011-1754","article-title":"Reproductive and metabolic phenotype of a mouse model of PCOS","volume":"153","author":"van Houten","year":"2012","journal-title":"Endocrinology"},{"issue":"34","key":"10.1016\/j.molmet.2020.01.001_bib123","doi-asserted-by":"crossref","first-page":"E7187","DOI":"10.1073\/pnas.1708854114","article-title":"Adiponectin protects against development of metabolic disturbances in a PCOS mouse model","volume":"114","author":"Benrick","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib124","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ped.13761","article-title":"Omentin-1 level in adolescents with polycystic ovarian syndrome","volume":"61","author":"Ozgen","year":"2019","journal-title":"Pediatrics International"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib125","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/db12-1430","article-title":"Anatomical locations of human brown adipose tissue: functional relevance and implications in obesity and type 2 diabetes","volume":"62","author":"Sacks","year":"2013","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cmet.2018.05.020","article-title":"Postprandial oxidative metabolism of human Brown fat indicates thermogenesis","volume":"28","author":"M. U.D.","year":"2018","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2020.01.001_bib127","first-page":"9","article-title":"Integrated control of brown adipose tissue","volume":"69","author":"Marzetti","year":"2016","journal-title":"Heart Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cen.13913","article-title":"Brown adipose tissue thermogenesis in polycystic ovary syndrome","volume":"90","author":"Shorakae","year":"2019","journal-title":"Clinical Endocrinology (Oxf)"},{"issue":"11","key":"10.1016\/j.molmet.2020.01.001_bib129","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1210\/en.2003-0537","article-title":"Direct effects of testosterone, 17 beta-estradiol, and progesterone on adrenergic regulation in cultured brown adipocytes: potential mechanism for gender-dependent thermogenesis","volume":"144","author":"Monjo","year":"2003","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib130","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1152\/ajpendo.00175.2006","article-title":"Expression of mitochondrial biogenesis-signaling factors in brown adipocytes is influenced specifically by 17beta-estradiol, testosterone, and progesterone","volume":"292","author":"Rodriguez-Cuenca","year":"2007","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2020.01.001_bib131","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1073\/pnas.1523236113","article-title":"Brown adipose tissue transplantation ameliorates polycystic ovary syndrome","volume":"113","author":"Yuan","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"key":"10.1016\/j.molmet.2020.01.001_bib132","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jnutbio.2017.04.012","article-title":"Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat","volume":"47","author":"Hu","year":"2017","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib133","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s13238-017-0378-6","article-title":"Common and distinct regulation of human and mouse brown and beige adipose tissues: a promising therapeutic target for obesity","volume":"8","author":"Liu","year":"2017","journal-title":"Protein Cell"},{"issue":"15","key":"10.1016\/j.molmet.2020.01.001_bib134","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"van Marken Lichtenbelt","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1016\/j.molmet.2020.01.001_bib135","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1016\/j.molmet.2020.01.001_bib136","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.molmet.2020.01.001_bib137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev-nutr-072610-145209","article-title":"The implication of brown adipose tissue for humans","volume":"31","author":"Ravussin","year":"2011","journal-title":"Annual Review of Nutrition"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib138","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/JOE-18-0598","article-title":"Adipose tissue browning in mice and humans","volume":"241","author":"Herz","year":"2019","journal-title":"Journal of Endocrinology"},{"issue":"12","key":"10.1016\/j.molmet.2020.01.001_bib139","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"Journal of Endocrinological Investigation"},{"issue":"11","key":"10.1016\/j.molmet.2020.01.001_bib140","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib141","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A\u00a0potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reproductive Health"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib142","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"47","author":"Cerda","year":"2007","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib143","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2020.01.001_bib144","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2020.01.001_bib145","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2009-2698","article-title":"Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome","volume":"95","author":"Chen","year":"2010","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib146","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Human Reproduction"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib147","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"International Journal of Obesity (Lond)"},{"issue":"26","key":"10.1016\/j.molmet.2020.01.001_bib148","doi-asserted-by":"crossref","first-page":"18180","DOI":"10.18632\/oncotarget.24477","article-title":"Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver","volume":"9","author":"Zhang","year":"2018","journal-title":"OncoTarget"},{"key":"10.1016\/j.molmet.2020.01.001_bib149","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1479-5876-11-133","article-title":"Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS)","volume":"11","author":"Baranova","year":"2013","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/JOE-15-0471","article-title":"Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism","volume":"230","author":"Abruzzese","year":"2016","journal-title":"Journal of Endocrinology"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib151","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/oby.21033","article-title":"The role of androgens in metabolism, obesity, and diabetes in males and females","volume":"23","author":"Navarro","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib152","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib153","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2337\/db07-0706","article-title":"Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment","volume":"57","author":"Hojlund","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2020.01.001_bib154","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2019-00167","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Unraveling the conundrum in skeletal muscle?","author":"Stepto","year":"2019","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib155","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1210\/jc.2018-01771","article-title":"Molecular mechanisms in skeletal muscle underlying insulin resistance in women who are lean with polycystic ovary syndrome","volume":"104","author":"Hansen","year":"2019","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"4 Pt 1","key":"10.1016\/j.molmet.2020.01.001_bib156","first-page":"E555","article-title":"Effects of testosterone on muscle insulin sensitivity and morphology in female rats","volume":"259","author":"Holmang","year":"1990","journal-title":"American Journal of Physiology"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib157","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-201X.2001.00801.x","article-title":"Insulin insensitivity and delayed transcapillary delivery of insulin in oophorectomized rats treated with testosterone","volume":"171","author":"Holmang","year":"2001","journal-title":"Acta Physiologica Scandinavica"},{"issue":"15","key":"10.1016\/j.molmet.2020.01.001_bib158","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.18632\/oncotarget.24190","article-title":"Dehydroepiandrosterone-induced activation of mTORC1 and inhibition of autophagy contribute to skeletal muscle insulin resistance in a mouse model of polycystic ovary syndrome","volume":"9","author":"Song","year":"2018","journal-title":"OncoTarget"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib159","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mrd.23111","article-title":"Nontargeted metabolomic analysis of skeletal muscle in a dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome","volume":"86","author":"Shen","year":"2019","journal-title":"Molecular Reproduction and Development"},{"key":"10.1016\/j.molmet.2020.01.001_bib160","first-page":"6869705","article-title":"Association of androgen excess with glucose intolerance in women with polycystic ovary syndrome","volume":"2018","author":"Zhang","year":"2018","journal-title":"BioMed Research International"},{"key":"10.1016\/j.molmet.2020.01.001_bib161","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-18-0573","article-title":"Emerging role of testosterone in pancreatic beta cell function and insulin secretion","author":"Xu","year":"2019","journal-title":"Journal of Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056263","article-title":"The pancreas is altered by in utero androgen exposure: implications for clinical conditions such as polycystic ovary syndrome (PCOS)","volume":"8","author":"Rae","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.molmet.2020.01.001_bib163","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00173.2019","article-title":"Fetal androgen signaling defects affect beta cell mass and function, leading to glucose intolerance in high-fat diet-fed male rats","author":"Harada","year":"2019","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"12","key":"10.1016\/j.molmet.2020.01.001_bib164","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98607","article-title":"Androgen excess in pancreatic beta cells and neurons predisposes female mice to type 2 diabetes","volume":"3","author":"Navarro","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2020.01.001_bib165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsbmb.2015.09.003","article-title":"Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function","volume":"154","author":"Wang","year":"2015","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011302","article-title":"Androgen excess produces systemic oxidative stress and predisposes to beta cell failure in female mice","volume":"5","author":"Liu","year":"2010","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib167","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cmet.2016.03.015","article-title":"Extranuclear actions of the androgen receptor enhance glucose-stimulated insulin secretion in the male","volume":"23","author":"Navarro","year":"2016","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2020.01.001_bib168","doi-asserted-by":"crossref","first-page":"27408","DOI":"10.1038\/srep27408","article-title":"Developmental programming of polycystic ovary syndrome (PCOS): prenatal androgens establish pancreatic islet\u00a0alpha\/beta cell ratio and subsequent insulin secretion","volume":"6","author":"Ramaswamy","year":"2016","journal-title":"Scientific Reports"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib169","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106527","article-title":"Abnormal infant islet morphology precedes insulin resistance in PCOS-like monkeys","volume":"9","author":"Nicol","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib170","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/jc.2013-3177","article-title":"Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic beta cell dysfunction in polycystic ovary syndrome","volume":"99","author":"Malin","year":"2014","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib171","doi-asserted-by":"crossref","first-page":"E770","DOI":"10.1152\/ajpendo.00510.2014","article-title":"Pancreatic beta cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-kappaB activation and systemic inflammation","volume":"308","author":"Malin","year":"2015","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib172","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2826.2011.02126.x","article-title":"Prenatal programming by testosterone of hypothalamic metabolic control neurones in the Ewe","volume":"23","author":"Sheppard","year":"2011","journal-title":"Journal of Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib173","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cmet.2007.05.004","article-title":"Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production","volume":"5","author":"Konner","year":"2007","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib174","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1210\/en.2010-1288","article-title":"Early-life exposure to testosterone programs the hypothalamic melanocortin system","volume":"152","author":"Nohara","year":"2011","journal-title":"Endocrinology"},{"issue":"16","key":"10.1016\/j.molmet.2020.01.001_bib175","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"key":"10.1016\/j.molmet.2020.01.001_bib176","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib177","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/2042018810380215","article-title":"Role of metformin in the management of polycystic ovary syndrome","volume":"1","author":"Lashen","year":"2010","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.molmet.2020.01.001_bib178","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1177\/1933719109340925","article-title":"Metformin does not improve the reproductive or metabolic profile in women with polycystic ovary syndrome (PCOS)","volume":"16","author":"Aubuchon","year":"2009","journal-title":"Reproductive Sciences"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib179","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2125.2002.01575.x","article-title":"Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice","volume":"53","author":"Sturrock","year":"2002","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib180","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.molmet.2020.01.001_bib181","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","article-title":"Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome","volume":"90","author":"Palomba","year":"2005","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"2 Pt 2","key":"10.1016\/j.molmet.2020.01.001_bib182","first-page":"271","article-title":"[Mechanisms of action of thiazolidinediones]","volume":"27","author":"Girard","year":"2001","journal-title":"Diabetes & Metabolism"},{"issue":"8","key":"10.1016\/j.molmet.2020.01.001_bib183","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1210\/en.2010-0124","article-title":"Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep","volume":"151","author":"Veiga-Lopez","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib184","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.reprotox.2006.12.009","article-title":"Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys","volume":"23","author":"Zhou","year":"2007","journal-title":"Reproductive Toxicology"},{"issue":"9","key":"10.1016\/j.molmet.2020.01.001_bib185","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s12325-012-0044-6","article-title":"Effects of thiazolidinediones on polycystic ovary syndrome: a meta-analysis of randomized placebo-controlled trials","volume":"29","author":"Du","year":"2012","journal-title":"Advances in Therapy"},{"issue":"5","key":"10.1016\/j.molmet.2020.01.001_bib186","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tem.2016.03.004","article-title":"Glucagon-like peptide 1 analogs and their effects on pancreatic islets","volume":"27","author":"Tuduri","year":"2016","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib187","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/17446651.2014.914850","article-title":"The potential of glucagon-like peptide 1 to reverse high-fat, high-sugar diet-related metabolic damage","volume":"9","author":"Muller","year":"2014","journal-title":"Expert Review of Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2020.01.001_bib188","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/17512433.2017.1292125","article-title":"GLP-1 receptor agonists in the treatment of polycystic ovary syndrome","volume":"10","author":"Lamos","year":"2017","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1016\/j.molmet.2020.01.001_bib189","first-page":"140","article-title":"The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study","volume":"5","author":"Rasmussen","year":"2014","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"1","key":"10.1016\/j.molmet.2020.01.001_bib190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03401383","article-title":"A\u00a012-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome","volume":"14","author":"Jensterle","year":"2015","journal-title":"Hormones (Athens)"},{"issue":"2","key":"10.1016\/j.molmet.2020.01.001_bib191","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reproductive BioMedicine Online"},{"issue":"7","key":"10.1016\/j.molmet.2020.01.001_bib192","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2020.01.001_bib193","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/EJE-13-0797","article-title":"Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin","volume":"170","author":"Jensterle Sever","year":"2014","journal-title":"European Journal of Endocrinology"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib194","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.soard.2019.03.032","article-title":"Effects of bariatric surgery on obese polycystic ovary syndrome: a systematic review and meta-analysis","volume":"15","author":"Li","year":"2019","journal-title":"Surgery for Obesity and Related Diseases"},{"issue":"7","key":"10.1016\/j.molmet.2020.01.001_bib195","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s11695-017-2547-3","article-title":"Evaluation of metabolic syndrome in morbidly obese patients submitted to laparoscopic bariatric surgery: comparison of the results between roux-En-Y gastric bypass and sleeve gastrectomy","volume":"27","author":"Menguer","year":"2017","journal-title":"Obesity Surgery"},{"issue":"6","key":"10.1016\/j.molmet.2020.01.001_bib196","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s11695-013-1153-2","article-title":"Metabolic, behavioral, and reproductive effects of vertical sleeve gastrectomy in an obese rat model of polycystic ovary syndrome","volume":"24","author":"Ressler","year":"2014","journal-title":"Obesity Surgery"},{"key":"10.1016\/j.molmet.2020.01.001_bib197","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.peptides.2017.12.021","article-title":"Gut hormone polyagonists for the treatment of type 2 diabetes","volume":"100","author":"Brandt","year":"2018","journal-title":"Peptides"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221287782030003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221287782030003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:21:42Z","timestamp":1761956502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221287782030003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":197,"alternative-id":["S221287782030003X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100937"}}